Salim S. Hayek

16.0k total citations
149 papers, 3.5k citations indexed

About

Salim S. Hayek is a scholar working on Cardiology and Cardiovascular Medicine, Oncology and Epidemiology. According to data from OpenAlex, Salim S. Hayek has authored 149 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Cardiology and Cardiovascular Medicine, 23 papers in Oncology and 21 papers in Epidemiology. Recurrent topics in Salim S. Hayek's work include COVID-19 Clinical Research Studies (16 papers), Cardiac Imaging and Diagnostics (12 papers) and Cardiac Valve Diseases and Treatments (12 papers). Salim S. Hayek is often cited by papers focused on COVID-19 Clinical Research Studies (16 papers), Cardiac Imaging and Diagnostics (12 papers) and Cardiac Valve Diseases and Treatments (12 papers). Salim S. Hayek collaborates with scholars based in United States, Germany and Canada. Salim S. Hayek's co-authors include Arshed A. Quyyumi, Stamatios Lerakis, Yi‐An Ko, Pamela S. Douglas, Mosaab Awad, Laurence Sperling, Jochen Reiser, Changli Wei, Greg S. Martin and Ayman Samman Tahhan and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Circulation.

In The Last Decade

Salim S. Hayek

140 papers receiving 3.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Salim S. Hayek United States 33 1.4k 503 478 427 390 149 3.5k
Daisuke Sugiyama Japan 30 568 0.4× 735 1.5× 516 1.1× 454 1.1× 222 0.6× 131 3.8k
Morten Schou Denmark 34 2.2k 1.6× 300 0.6× 598 1.3× 643 1.5× 182 0.5× 188 4.0k
Rajeev Malhotra United States 39 2.4k 1.7× 430 0.9× 926 1.9× 1.1k 2.6× 388 1.0× 163 5.9k
Yaron Arbel Israel 31 2.3k 1.6× 846 1.7× 236 0.5× 590 1.4× 601 1.5× 181 4.0k
Jianzeng Dong China 35 3.6k 2.5× 496 1.0× 713 1.5× 513 1.2× 281 0.7× 442 5.5k
Kyungdo Han South Korea 27 595 0.4× 1.0k 2.1× 543 1.1× 430 1.0× 323 0.8× 276 3.6k
John‐Bjarne Hansen Norway 40 1.6k 1.1× 585 1.2× 631 1.3× 444 1.0× 489 1.3× 194 4.5k
Αναστάσιος Κόλλιας Greece 35 2.3k 1.6× 360 0.7× 406 0.8× 266 0.6× 353 0.9× 184 4.6k
Patrick R. Lawler Canada 34 1.4k 1.0× 596 1.2× 920 1.9× 274 0.6× 249 0.6× 124 4.3k
Lori B. Daniels United States 39 2.9k 2.0× 562 1.1× 430 0.9× 1000 2.3× 180 0.5× 153 4.8k

Countries citing papers authored by Salim S. Hayek

Since Specialization
Citations

This map shows the geographic impact of Salim S. Hayek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salim S. Hayek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salim S. Hayek more than expected).

Fields of papers citing papers by Salim S. Hayek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Salim S. Hayek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salim S. Hayek. The network helps show where Salim S. Hayek may publish in the future.

Co-authorship network of co-authors of Salim S. Hayek

This figure shows the co-authorship network connecting the top 25 collaborators of Salim S. Hayek. A scholar is included among the top collaborators of Salim S. Hayek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Salim S. Hayek. Salim S. Hayek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Richards, Blair, James M. Rae, Robert T. Dess, et al.. (2025). Factors Associated With the Recovery of Left Ventricular Ejection Fraction in Patients With Anthracycline-Induced Left Ventricular Dysfunction. Journal of Cardiovascular Pharmacology and Therapeutics. 30. 2234862320–2234862320. 1 indexed citations
3.
Liu, Chang, et al.. (2025). Proteomics‐Based Soluble Urokinase Plasminogen Activator Receptor Levels and Long‐Term Cardiovascular Outcomes in Survivors of Breast Cancer: A UK Biobank Study. Journal of the American Heart Association. 14(9). e039728–e039728. 1 indexed citations
4.
Vasbinder, Alexi, Élizabeth Anderson, Tonimarie Catalan, et al.. (2024). Incidence of Immune Checkpoint Inhibitor–Induced Myocarditis During the COVID‐19 Pandemic. Journal of the American Heart Association. 13(6). e032667–e032667. 1 indexed citations
5.
Ang, Lynn, Yiyuan Huang, Catherine L. Martin, et al.. (2024). Inflammatory Markers and Measures of Cardiovascular Autonomic Neuropathy in Type 1 Diabetes. Journal of the American Heart Association. 14(1). e036787–e036787. 2 indexed citations
6.
Jain, Vardhmaan, Anurag Mehta, Chang Liu, et al.. (2023). Immune Activation Mediates the Association of Advanced Hepatic Fibrosis With Adverse Outcomes in Patients With Coronary Artery Disease. Journal of the American Heart Association. 12(24). e031230–e031230. 7 indexed citations
7.
Zhu, Ke, Kamalika Mukherjee, Changli Wei, et al.. (2023). The D2D3 form of uPAR acts as an immunotoxin and may cause diabetes and kidney disease. Science Translational Medicine. 15(714). eabq6492–eabq6492. 1 indexed citations
8.
Vasbinder, Alexi, Tonimarie Catalan, Pennelope Blakely, et al.. (2022). Metastatic melanoma of the heart: Retrospective cohort study and systematic review of prevalence, clinical characteristics, and outcomes. Cancer Medicine. 12(3). 2356–2367. 8 indexed citations
9.
Vasbinder, Alexi, Chelsea Meloche, Tariq U. Azam, et al.. (2022). Relationship Between Preexisting Cardiovascular Disease and Death and Cardiovascular Outcomes in Critically Ill Patients With COVID-19. Circulation Cardiovascular Quality and Outcomes. 15(10). e008942–e008942. 20 indexed citations
10.
Acharya, Prakash, Sagar Ranka, Jinxiang Hu, et al.. (2021). Incidence, Predictors, and Outcomes of In‐Hospital Cardiac Arrest in COVID‐19 Patients Admitted to Intensive and Non‐Intensive Care Units: Insights From the AHA COVID‐19 CVD Registry. Journal of the American Heart Association. 10(16). e021204–e021204. 19 indexed citations
11.
Hladunewich, Michelle, D C Cattran, Sanjeev Sethi, et al.. (2021). Efficacy of Rituximab in Treatment-Resistant Focal Segmental Glomerulosclerosis With Elevated Soluble Urokinase-Type Plasminogen Activator Receptor and Activation of Podocyte β3 Integrin. Kidney International Reports. 7(1). 68–77. 10 indexed citations
12.
Tehrani, David M., Xiaoyan Wang, Asim Rafique, et al.. (2021). Impact of cancer and cardiovascular disease on in-hospital outcomes of COVID-19 patients: results from the american heart association COVID-19 cardiovascular disease registry. Cardio-Oncology. 7(1). 28–28. 7 indexed citations
13.
Gupta, Sweety, et al.. (2021). STOP-COVID Investigators. Factors associated with death in critically ill patients with coronavirus disease 2019 in the US (vol 180, pg 1436, 2020). JAMA Internal Medicine. 181(8). 1144–1144. 1 indexed citations
14.
Molnar, Miklos Z., Anshul Bhalla, Makoto Tsujita, et al.. (2020). Outcomes of critically ill solid organ transplant patients with COVID-19 in the United States. American Journal of Transplantation. 20(11). 3061–3071. 71 indexed citations
15.
Corrigan, Frank, John Lisko, Salim S. Hayek, et al.. (2018). Mean Aortic pressure gradient and global longitudinal strain recovery after transcatheter aortic valve replacement – A retrospective analysis. Hellenic Journal of Cardiology. 59(5). 268–271. 6 indexed citations
16.
Tahhan, Ayman Samman, Salim S. Hayek, Pratik B. Sandesara, et al.. (2017). Circulating soluble urokinase plasminogen activator receptor levels and peripheral arterial disease outcomes. Atherosclerosis. 264. 108–114. 23 indexed citations
17.
Hahm, Eunsil, Changli Wei, Isabel Cuesta Fernández, et al.. (2016). Bone marrow-derived immature myeloid cells are a main source of circulating suPAR contributing to proteinuric kidney disease. Nature Medicine. 23(1). 100–106. 101 indexed citations
18.
Corrigan, Frank, Ibhar Al Mheid, Danny J. Eapen, et al.. (2015). Low testosterone in men predicts impaired arterial elasticity and microvascular function. International Journal of Cardiology. 194. 94–99. 45 indexed citations
19.
Awwad, Johnny, IM Usta, Ghina Ghazeeri, et al.. (2014). A randomised controlled double‐blind clinical trial of 17‐hydroxyprogesterone caproate for the prevention of preterm birth in twin gestation ( PROGESTWIN ): evidence for reduced neonatal morbidity. BJOG An International Journal of Obstetrics & Gynaecology. 122(1). 71–79. 26 indexed citations
20.
Hayek, Salim S., Joseph Poole, Robert B. Neuman, et al.. (2014). Differential effects of nebivolol and metoprolol on arterial stiffness, circulating progenitor cells, and oxidative stress. Journal of the American Society of Hypertension. 9(3). 206–213. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026